<VariationArchive VariationID="16020" VariationName="NM_002087.4(GRN):c.813_816del (p.Thr272fs)" VariationType="Deletion" Accession="VCV000016020" Version="30" RecordType="classified" NumberOfSubmissions="8" NumberOfSubmitters="6" DateLastUpdated="2024-07-29" DateCreated="2014-02-20" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="31059" VariationID="16020">
      <GeneList>
        <Gene Symbol="GRN" FullName="granulin precursor" GeneID="2896" HGNC_ID="HGNC:4601" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="44345302" stop="44353106" display_start="44345302" display_stop="44353106" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="42422490" stop="42430469" display_start="42422490" display_stop="42430469" Strand="+" />
          </Location>
          <OMIM>138945</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_002087.4(GRN):c.813_816del (p.Thr272fs)</Name>
      <CanonicalSPDI>NC_000017.11:44351138:CTCACT:CT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q21.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="44351139" stop="44351142" display_start="44351139" display_stop="44351142" variantLength="4" positionVCF="44351138" referenceAlleleVCF="CCTCA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="42428507" stop="42428510" display_start="42428507" display_stop="42428510" variantLength="4" positionVCF="42428506" referenceAlleleVCF="CCTCA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>T272fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_661" sequenceAccession="LRG_661">
            <Expression>LRG_661:g.11019_11022del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.42428509_42428512del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.42428509_42428512del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.44351141_44351144del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.44351141_44351144del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007886.1" sequenceAccession="NG_007886" sequenceVersion="1" change="g.11019_11022del">
            <Expression>NG_007886.1:g.11019_11022del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002087.4" sequenceAccession="NM_002087" sequenceVersion="4" change="c.813_816del" MANESelect="true">
            <Expression>NM_002087.4:c.813_816del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002078.1" sequenceAccession="NP_002078" sequenceVersion="1" change="p.Thr272fs">
            <Expression>NP_002078.1:p.Thr272fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007886.1" sequenceAccession="NG_007886" sequenceVersion="1" change="g.11019_11022delCACT">
            <Expression>NG_007886.1:g.11019_11022delCACT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002087.2" sequenceAccession="NM_002087" sequenceVersion="2" change="c.813_816del">
            <Expression>NM_002087.2:c.813_816del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_661t1" sequenceAccession="LRG_661t1">
            <Expression>LRG_661t1:c.813_816del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA126151" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="138945.0015" DB="OMIM" />
        <XRef Type="rs" ID="63749877" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002087.4(GRN):c.813_816del (p.Thr272fs) AND Primary progressive aphasia" Accession="RCV000017394" Version="38">
        <ClassifiedConditionList TraitSetID="5203">
          <ClassifiedCondition DB="MedGen" ID="C0282513">Primary progressive aphasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2012-06-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_002087.4(GRN):c.813_816del (p.Thr272fs) AND GRN-related frontotemporal lobar degeneration with Tdp43 inclusions" Accession="RCV000017393" Version="36">
        <ClassifiedConditionList TraitSetID="5202">
          <ClassifiedCondition DB="MedGen" ID="C1843792">GRN-related frontotemporal lobar degeneration with Tdp43 inclusions</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-05-04" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_002087.4(GRN):c.813_816del (p.Thr272fs) AND Neuronal ceroid lipofuscinosis 11" Accession="RCV000029169" Version="38">
        <ClassifiedConditionList TraitSetID="8710">
          <ClassifiedCondition DB="MedGen" ID="C3539123">Neuronal ceroid lipofuscinosis 11</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2012-06-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_002087.4(GRN):c.813_816del (p.Thr272fs) AND not provided" Accession="RCV000084585" Version="27">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-09-12" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_002087.4(GRN):c.813_816del (p.Thr272fs) AND multiple conditions" Accession="RCV001851888" Version="11">
        <ClassifiedConditionList TraitSetID="12962">
          <ClassifiedCondition DB="MedGen" ID="C1843792">GRN-related frontotemporal lobar degeneration with Tdp43 inclusions</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3539123">Neuronal ceroid lipofuscinosis 11</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-10-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-09-12" NumberOfSubmissions="8" NumberOfSubmitters="6" DateCreated="2014-02-20" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16862116</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16950801</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18245784</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18392865</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20522652</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20947212</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21891869</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22127750</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22608501</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32507413</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33203472</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="12962" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17311" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Neuronal ceroid lipofuscinosis 11</ElementValue>
                <XRef ID="MONDO:0013866" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GRN-Related Neuronal Ceroid-Lipofuscinosis</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CLN11</ElementValue>
                <XRef Type="MIM" ID="614706" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17426" />
                <XRef ID="17426" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="314629" DB="Orphanet" />
              <XRef ID="79262" DB="Orphanet" />
              <XRef ID="C3539123" DB="MedGen" />
              <XRef ID="MONDO:0013866" DB="MONDO" />
              <XRef Type="MIM" ID="614706" DB="OMIM" />
            </Trait>
            <Trait ID="5167" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">GRN-related frontotemporal lobar degeneration with Tdp43 inclusions</ElementValue>
                <XRef ID="MONDO:0011842" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GRN-Related Frontotemporal Dementia</ElementValue>
                <XRef ID="NBK1371" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, GRN-RELATED</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Frontotemporal dementia, ubiquitin-positive</ElementValue>
                <XRef ID="Frontotemporal+Dementia%2C+Ubiquitin-Positive/2945" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dementia, hereditary dysphasic disinhibition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0019" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0017" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0011" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">FTLD-TDP, GRN-RELATED</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HDDD</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FTDU</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FTLDU</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000551442" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530102" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of GRN frontotemporal dementia (GRN-FTD) includes the behavioral variant (bvFTD), primary progressive aphasia (PPA; further subcategorized as progressive nonfluent aphasia [PNFA] and semantic dementia [SD]), and movement disorders with extrapyramidal features such as parkinsonism and corticobasal syndrome (CBS). A broad range of clinical features both within and between families is observed. The age of onset ranges from 35 to 87 years. Behavioral disturbances are the most common early feature, followed by progressive aphasia. Impairment in executive function manifests as loss of judgment and insight. In early stages, PPA often manifests as deficits in naming, word finding, or word comprehension. In late stages, affected individuals often become mute and lose their ability to communicate. Early findings of parkinsonism include rigidity, bradykinesia or akinesia (slowing or absence of movements), limb dystonia, apraxia (loss of ability to carry out learned purposeful movements), and disequilibrium. Late motor findings may include myoclonus, dysarthria, and dysphagia. Most affected individuals eventually lose the ability to walk. Disease duration is three to 12 years.</Attribute>
                <XRef ID="NBK1371" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301545</ID>
                <ID Source="BookShelf">NBK1371</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <XRef ID="100070" DB="Orphanet" />
              <XRef ID="282" DB="Orphanet" />
              <XRef ID="C1843792" DB="MedGen" />
              <XRef ID="MONDO:0011842" DB="MONDO" />
              <XRef Type="MIM" ID="607485" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5202" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5167" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">GRN-related frontotemporal lobar degeneration with Tdp43 inclusions</ElementValue>
                <XRef ID="MONDO:0011842" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GRN-Related Frontotemporal Dementia</ElementValue>
                <XRef ID="NBK1371" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, GRN-RELATED</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Frontotemporal dementia, ubiquitin-positive</ElementValue>
                <XRef ID="Frontotemporal+Dementia%2C+Ubiquitin-Positive/2945" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dementia, hereditary dysphasic disinhibition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0019" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0017" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="138945.0011" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">FTLD-TDP, GRN-RELATED</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HDDD</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FTDU</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FTLDU</ElementValue>
                <XRef Type="MIM" ID="607485" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000551442" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530102" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of GRN frontotemporal dementia (GRN-FTD) includes the behavioral variant (bvFTD), primary progressive aphasia (PPA; further subcategorized as progressive nonfluent aphasia [PNFA] and semantic dementia [SD]), and movement disorders with extrapyramidal features such as parkinsonism and corticobasal syndrome (CBS). A broad range of clinical features both within and between families is observed. The age of onset ranges from 35 to 87 years. Behavioral disturbances are the most common early feature, followed by progressive aphasia. Impairment in executive function manifests as loss of judgment and insight. In early stages, PPA often manifests as deficits in naming, word finding, or word comprehension. In late stages, affected individuals often become mute and lose their ability to communicate. Early findings of parkinsonism include rigidity, bradykinesia or akinesia (slowing or absence of movements), limb dystonia, apraxia (loss of ability to carry out learned purposeful movements), and disequilibrium. Late motor findings may include myoclonus, dysarthria, and dysphagia. Most affected individuals eventually lose the ability to walk. Disease duration is three to 12 years.</Attribute>
                <XRef ID="NBK1371" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301545</ID>
                <ID Source="BookShelf">NBK1371</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <XRef ID="100070" DB="Orphanet" />
              <XRef ID="282" DB="Orphanet" />
              <XRef ID="C1843792" DB="MedGen" />
              <XRef ID="MONDO:0011842" DB="MONDO" />
              <XRef Type="MIM" ID="607485" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5203" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="6247" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Primary progressive aphasia syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Primary progressive aphasia</ElementValue>
                <XRef ID="MONDO:0019806" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PPA</ElementValue>
                <XRef ID="607485" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8541" />
                <XRef ID="8541" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="95432" DB="Orphanet" />
              <XRef ID="C0282513" DB="MedGen" />
              <XRef ID="MONDO:0019806" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8710" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17311" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Neuronal ceroid lipofuscinosis 11</ElementValue>
                <XRef ID="MONDO:0013866" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GRN-Related Neuronal Ceroid-Lipofuscinosis</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CLN11</ElementValue>
                <XRef Type="MIM" ID="614706" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17426" />
                <XRef ID="17426" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="314629" DB="Orphanet" />
              <XRef ID="79262" DB="Orphanet" />
              <XRef ID="C3539123" DB="MedGen" />
              <XRef ID="MONDO:0013866" DB="MONDO" />
              <XRef Type="MIM" ID="614706" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="37666" SubmissionDate="2021-02-12" DateLastUpdated="2021-02-20" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="138945.0015_APHASIA, PRIMARY PROGRESSIVE" title="GRN, 4-BP DEL, 813CACT (rs63749877)_APHASIA, PRIMARY PROGRESSIVE" />
        <ClinVarAccession Accession="SCV000037666" DateUpdated="2021-02-20" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-06-08">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Frontotemporal Lobar Degeneration and Aphasia</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 4 (1.64%) of 243 unrelated Italian patients with a clinical diagnosis of frontotemporal lobar degeneration (607485), Borroni et al. (2008) identified the same heterozygous 4-bp deletion (813delCACT) in exon 8 of the GRN gene, resulting in a frameshift and premature termination. Two female patients were diagnosed with the behavioral variant of frontotemporal dementia, and 2 males with progressive nonfluent aphasia. The estimated age at onset ranged from 53 to 64 years, and all showed evidence of hypoperfusion of the frontotemporal brain regions. Three of the 4 had a family history of the disorder. Considering all patients in the study with a well-known family history for dementia, the frequency of this mutation was 6% (4 of 84). Haplotype analysis indicated a founder effect.</Attribute>
              <Citation>
                <ID Source="PubMed">18392865</ID>
              </Citation>
              <XRef DB="OMIM" ID="607485" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Neuronal Ceroid Lipofuscinosis 11</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Smith et al. (2012) identified a homozygous 813_816 deletion in the GRN gene (rs63749877) in 2 sibs, born of distantly related Italian parents, with young-adult onset of neuronal ceroid lipofuscinosis-11 (CLN11; 614706). The patients developed rapidly progressive visual failure in their early twenties, followed by retinal dystrophy, seizures, cerebellar ataxia, and cerebellar hypoplasia. One had cognitive decline. Skin biopsy of 1 patient showed numerous fingerprint profiles in membrane-bound structures in eccrine secretory cells and endothelium. Plasma progranulin levels in the homozygous patients were undetectable and were about 50% decreased in the heterozygous parents. Family history revealed 3 cases of late-onset dementia in both sides of the family, but DNA was not available from these patients. The healthy parents were in their fifties; the molecular findings suggested that they may be at risk for later-onset dementia. Ahmed et al. (2010) found that Grn-null mice developed abnormal accumulation of abnormal intraneuronal ubiquitin-positive autofluorescent lipofuscin, detected by light microscopy. Electron microscopic examination of fixed brain tissue from Grn-null showed abundant rectilinear profiles diagnostic of CLN. Smith et al. (2012) commented on the remarkable phenotypic differences between heterozygous and homozygous GRN mutations, and suggested that progranulin may have a lysosomal function.</Attribute>
              <Citation>
                <ID Source="PubMed">22608501</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">20522652</ID>
              </Citation>
              <XRef DB="OMIM" ID="614706" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GRN" />
          </GeneList>
          <Name>GRN, 4-BP DEL, 813CACT (rs63749877)</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP DEL, 813CACT (rs63749877)</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="138945.0015" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">APHASIA, PRIMARY PROGRESSIVE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="37665" SubmissionDate="2021-02-12" DateLastUpdated="2021-02-20" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="138945.0015_FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS" title="GRN, 4-BP DEL, 813CACT (rs63749877)_FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS" />
        <ClinVarAccession Accession="SCV000037665" DateUpdated="2021-02-20" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-06-08">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Frontotemporal Lobar Degeneration and Aphasia</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 4 (1.64%) of 243 unrelated Italian patients with a clinical diagnosis of frontotemporal lobar degeneration (607485), Borroni et al. (2008) identified the same heterozygous 4-bp deletion (813delCACT) in exon 8 of the GRN gene, resulting in a frameshift and premature termination. Two female patients were diagnosed with the behavioral variant of frontotemporal dementia, and 2 males with progressive nonfluent aphasia. The estimated age at onset ranged from 53 to 64 years, and all showed evidence of hypoperfusion of the frontotemporal brain regions. Three of the 4 had a family history of the disorder. Considering all patients in the study with a well-known family history for dementia, the frequency of this mutation was 6% (4 of 84). Haplotype analysis indicated a founder effect.</Attribute>
              <Citation>
                <ID Source="PubMed">18392865</ID>
              </Citation>
              <XRef DB="OMIM" ID="607485" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Neuronal Ceroid Lipofuscinosis 11</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Smith et al. (2012) identified a homozygous 813_816 deletion in the GRN gene (rs63749877) in 2 sibs, born of distantly related Italian parents, with young-adult onset of neuronal ceroid lipofuscinosis-11 (CLN11; 614706). The patients developed rapidly progressive visual failure in their early twenties, followed by retinal dystrophy, seizures, cerebellar ataxia, and cerebellar hypoplasia. One had cognitive decline. Skin biopsy of 1 patient showed numerous fingerprint profiles in membrane-bound structures in eccrine secretory cells and endothelium. Plasma progranulin levels in the homozygous patients were undetectable and were about 50% decreased in the heterozygous parents. Family history revealed 3 cases of late-onset dementia in both sides of the family, but DNA was not available from these patients. The healthy parents were in their fifties; the molecular findings suggested that they may be at risk for later-onset dementia. Ahmed et al. (2010) found that Grn-null mice developed abnormal accumulation of abnormal intraneuronal ubiquitin-positive autofluorescent lipofuscin, detected by light microscopy. Electron microscopic examination of fixed brain tissue from Grn-null showed abundant rectilinear profiles diagnostic of CLN. Smith et al. (2012) commented on the remarkable phenotypic differences between heterozygous and homozygous GRN mutations, and suggested that progranulin may have a lysosomal function.</Attribute>
              <Citation>
                <ID Source="PubMed">22608501</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">20522652</ID>
              </Citation>
              <XRef DB="OMIM" ID="614706" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GRN" />
          </GeneList>
          <Name>GRN, 4-BP DEL, 813CACT (rs63749877)</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP DEL, 813CACT (rs63749877)</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="138945.0015" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="55893" SubmissionDate="2021-02-12" DateLastUpdated="2021-02-20" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="138945.0015_CEROID LIPOFUSCINOSIS, NEURONAL, 11" title="GRN, 4-BP DEL, 813CACT (rs63749877)_CEROID LIPOFUSCINOSIS, NEURONAL, 11" />
        <ClinVarAccession Accession="SCV000051814" DateUpdated="2021-02-20" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-06-08">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Frontotemporal Lobar Degeneration and Aphasia</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 4 (1.64%) of 243 unrelated Italian patients with a clinical diagnosis of frontotemporal lobar degeneration (607485), Borroni et al. (2008) identified the same heterozygous 4-bp deletion (813delCACT) in exon 8 of the GRN gene, resulting in a frameshift and premature termination. Two female patients were diagnosed with the behavioral variant of frontotemporal dementia, and 2 males with progressive nonfluent aphasia. The estimated age at onset ranged from 53 to 64 years, and all showed evidence of hypoperfusion of the frontotemporal brain regions. Three of the 4 had a family history of the disorder. Considering all patients in the study with a well-known family history for dementia, the frequency of this mutation was 6% (4 of 84). Haplotype analysis indicated a founder effect.</Attribute>
              <Citation>
                <ID Source="PubMed">18392865</ID>
              </Citation>
              <XRef DB="OMIM" ID="607485" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Neuronal Ceroid Lipofuscinosis 11</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Smith et al. (2012) identified a homozygous 813_816 deletion in the GRN gene (rs63749877) in 2 sibs, born of distantly related Italian parents, with young-adult onset of neuronal ceroid lipofuscinosis-11 (CLN11; 614706). The patients developed rapidly progressive visual failure in their early twenties, followed by retinal dystrophy, seizures, cerebellar ataxia, and cerebellar hypoplasia. One had cognitive decline. Skin biopsy of 1 patient showed numerous fingerprint profiles in membrane-bound structures in eccrine secretory cells and endothelium. Plasma progranulin levels in the homozygous patients were undetectable and were about 50% decreased in the heterozygous parents. Family history revealed 3 cases of late-onset dementia in both sides of the family, but DNA was not available from these patients. The healthy parents were in their fifties; the molecular findings suggested that they may be at risk for later-onset dementia. Ahmed et al. (2010) found that Grn-null mice developed abnormal accumulation of abnormal intraneuronal ubiquitin-positive autofluorescent lipofuscin, detected by light microscopy. Electron microscopic examination of fixed brain tissue from Grn-null showed abundant rectilinear profiles diagnostic of CLN. Smith et al. (2012) commented on the remarkable phenotypic differences between heterozygous and homozygous GRN mutations, and suggested that progranulin may have a lysosomal function.</Attribute>
              <Citation>
                <ID Source="PubMed">22608501</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">20522652</ID>
              </Citation>
              <XRef DB="OMIM" ID="614706" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GRN" />
          </GeneList>
          <Name>GRN, 4-BP DEL, 813CACT (rs63749877)</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP DEL, 813CACT (rs63749877)</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="138945.0015" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">CEROID LIPOFUSCINOSIS, NEURONAL, 11</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4933215" SubmissionDate="2022-05-21" DateLastUpdated="2022-05-28" DateCreated="2022-05-28">
        <ClinVarSubmissionID localKey="NC_000017.11:g.44351139_44351142delCTCA|OMIM:607485" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002516527" DateUpdated="2022-05-28" DateCreated="2022-05-28" Type="SCV" Version="1" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Mendelics Assertion Criteria 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fxi2k7be/mendelics_assertion_criteria_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GRN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.11:g.44351139_44351142delCTCA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607485" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_033</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7902856" SubmissionDate="2024-01-03" DateLastUpdated="2024-01-26" DateCreated="2024-01-26">
        <ClinVarSubmissionID localKey="A19084|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004229837" DateUpdated="2024-01-26" DateCreated="2024-01-26" Type="SCV" Version="1" SubmitterName="Athena Diagnostics" OrgID="1012" OrganizationCategory="laboratory" OrgAbbreviation="ADX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22608501</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21891869</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20947212</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18392865</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18245784</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32507413</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33203472</ID>
          </Citation>
          <Comment>This variant is expected to result in the loss of a functional protein. This variant has been identified in multiple unrelated individuals with FTLD-TDP or neuronal ceroid lipofuscinosis. This variant has not been reported in large, multi-ethnic general populations (http://gnomad.broadinstitute.org).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Athena Diagnostics Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">26467025</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_002087.2:c.813_816del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14108777</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="204524" SubmissionDate="2013-02-13" DateLastUpdated="2014-02-20" DateCreated="2014-02-20">
        <ClinVarSubmissionID localKey="ADM_318" />
        <ClinVarAccession Accession="SCV000116721" DateUpdated="2014-02-20" DateCreated="2014-02-20" Type="SCV" Version="1" SubmitterName="VIB  Department of Molecular Genetics, University of Antwerp" OrgID="500316" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>not provided</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NG_007886.1:g.11019_11022delCACT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Comment>http://phencode.bx.psu.edu/cgi-bin/phencode/phencode?build=hg18&amp;id=ADM_318</Comment>
        <SubmissionNameList>
          <SubmissionName>VIB_MOLGEN_ADFTDMDB_2008_3_21</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4261459" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="4942966|MedGen:C3539123;C1843792" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002243971" DateUpdated="2024-02-28" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18245784</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20947212</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21891869</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22127750</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22608501</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16862116</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16950801</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22608501</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 16020). This premature translational stop signal has been observed in individuals with autosomal dominant frontotemporal dementia and autosomal recessive neuronal ceroid lipofuscinosis (PMID: 18245784, 20947212, 21891869, 22127750, 22608501). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Thr272Serfs*10) in the GRN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GRN are known to be pathogenic (PMID: 16862116, 16950801, 22608501).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GRN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.42428507_42428510del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3539123" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1843792" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2472031" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2020-05-12">
        <ClinVarSubmissionID localKey="101864|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001250432" DateUpdated="2024-07-15" DateCreated="2020-05-12" Type="SCV" Version="23" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-02-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GRN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="17" alternateAllele="C" referenceAllele="CCTCA" start="42428506" stop="42428510" variantLength="5" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2021-07</SubmissionName>
          <SubmissionName>2021-10</SubmissionName>
          <SubmissionName>2022-01</SubmissionName>
          <SubmissionName>2022-01-corrected</SubmissionName>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-08</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="37665" TraitType="Disease" MappingType="Name" MappingValue="FRONTOTEMPORAL LOBAR DEGENERATION WITH UBIQUITIN-POSITIVE INCLUSIONS" MappingRef="Preferred">
        <MedGen CUI="C1843792" Name="GRN-related frontotemporal lobar degeneration with Tdp43 inclusions" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="204524" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4261459" TraitType="Disease" MappingType="XRef" MappingValue="C3539123" MappingRef="MedGen">
        <MedGen CUI="C3539123" Name="Neuronal ceroid lipofuscinosis 11" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2472031" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="55893" TraitType="Disease" MappingType="Name" MappingValue="CEROID LIPOFUSCINOSIS, NEURONAL, 11" MappingRef="Alternate">
        <MedGen CUI="C3539123" Name="Neuronal ceroid lipofuscinosis 11" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4933215" TraitType="Disease" MappingType="XRef" MappingValue="607485" MappingRef="OMIM">
        <MedGen CUI="C1843792" Name="GRN-related frontotemporal lobar degeneration with Tdp43 inclusions" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="37666" TraitType="Disease" MappingType="Name" MappingValue="APHASIA, PRIMARY PROGRESSIVE" MappingRef="Alternate">
        <MedGen CUI="C0282513" Name="Primary progressive aphasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4261459" TraitType="Disease" MappingType="XRef" MappingValue="C1843792" MappingRef="MedGen">
        <MedGen CUI="C1843792" Name="GRN-related frontotemporal lobar degeneration with Tdp43 inclusions" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7902856" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

